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General Abstract 
 
 Haemophilus influenzae is a significant opportunistic pathogen that causes a range 
of respiratory infections, including community-acquired pneumonia (CAP), acute 
exacerbations of chronic obstructive pulmonary disease (COPD) and acute otitis 
media (AOM). These infections frequently require antibiotic therapy for 
management, with antibiotics of the β-lactam class such as amoxicillin, cefaclor, and 
amoxicillin-clavulanate historically used as first line therapies. However, the efficacy 
of these antibiotics is currently threatened by the increasing prevalence of β-lactam 
resistance mediated by specific mutations in the ftsI gene that produce an N526K 
substitution in the encoded penicillin-binding protein 3 (PBP3), a protein that is the 
target of these antibiotics. This type of resistance, termed β-lactamase-negative 
ampicillin-resistance (BLNAR), is difficult to detect in the diagnostic laboratory, as 
many BLNAR isolates do not actually show an ampicillin resistant phenotype using 
standard susceptibility testing methods. As a result genotypic testing methods are 
being increasingly adopted for BLNAR detection. Furthermore, the recent 
recognition of Haemophilus haemolyticus, a close non-pathogenic relative of H. 
influenzae, in diagnostic specimens from the respiratory tract, has compounded the 
issue. This is because H. haemolyticus isolates are frequently mis-identified as H. 
influenzae, which further complicates the role of the diagnostic laboratory in 
guiding antibiotic therapy for infections involving H. influenzae.  
A working strain collection comprising a total of 393 Haemophilus isolates was 
established and used for all the subsequent studies conducted in this thesis. Isolates 
were taken from; 1) the University of Tasmania (UTAS) culture collection (n=44), 
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that had been previously collected from cases of respiratory illness, and 2) the 
Genetics of Recurrent Otitis Media and Immunology in Toddlers (GROMIT) Study 
conducted in Perth, Western Australia, where 349 XV-dependent Haemophilus 
isolates were cultured from paediatric patients suffering AOM with healthy aged-
matched controls. 
In Chapter 3, the SNP-based PCR algorithm of Hasegawa et al. (2003) that has been 
widely used to detect BLNAR mediated resistance was evaluated against the less 
commonly used PCR algorithm of Nakamura et al. (2009). Although, the primer set 
(PBP3-S) of Hasegawa et al. (2003), that is designed to amplify susceptible (N526) 
isolates was 100% sensitive and specific for detecting N526K-positive BLNAR 
isolates by non-amplification, the primer set (PBP3-BLN) designed to amplify N526K 
isolates was unreliable (sensitivity 84%; specificity 26%). Similar findings were 
reported for the sensitivity and specificity of the Nakamura et al. (2009) primers for 
detecting the N526K substitution in BLNAR isolates by amplification (sensitivity 96%; 
specificity 26%).  The poor performance of these PCR primers was attributed to the 
fact that the N526K substitution can be encoded by an AAT-AAG codon change at 
base pair (bp) position 1576-1578 of ftsI, as well as the recently described AAT-AAA 
codon change. As the PCR primers investigated were designed for detection of the 
N526K substitution encoded by the AAG SNP only, they failed to detect N526K 
encoded by AAA. A search of ftsI gene sequences available on GenBank revealed 
that the AAT to AAG or AAA codon changes occurred with equal prevalence in 
N526K-positive BLNAR isolates, suggesting that the prevalence of BLNAR isolates 
would go under-reported when these PCR algorithms were used for BLNAR 
detection.  
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Little was known about the β-lactam resistance profile of H. haemolyticus, a 
respiratory commensal commonly mis-identified as H. influenzae in the diagnostic 
laboratory. As a result, Chapter 4 examined the phenotypic and genotypic 
characteristics of β-lactam resistance mechanisms in a large collection of H. 
haemolyticus and H. influenzae isolates, collected during the GROMIT study using a 
well defined patient population. The prevalence and mechanisms of β-lactam 
resistance were identified to be similar for both bacterial species, with 13.1% of H. 
haemolyticus, and 15.7% of H. influenzae isolates harbouring the TEM-1 β-
lactamase (with the same replicon and promoter types commonly reported in H. 
influenzae identified in H. haemolyticus), whilst 31.0% of both H. haemolyticus and 
H. influenzae isolates were positive for the N526K BLNAR-defining substitution. 
Further analysis of the ftsI gene encoding PBP3 in these N526K-positive BLNAR 
isolates revealed that some of the commonly recognized BLNAR-associated 
substitutions in H. influenzae form part of the baseline PBP3 sequence in H. 
haemolyticus. This suggests that respiratory isolates of H. haemolyticus might 
possibly represent a significant reservoir for β-lactam resistance determinants in co-
localised H. influenzae. 
Examination of the ftsI gene sequences of the H. haemolyticus isolates from Chapter 
4 revealed some differences that might interfere with the SNP-based PCR assays of 
Hasegawa et al. (2003) that were previously evaluated in Chapter 3 using only H. 
influenzae isolates. When evaluated against a panel of susceptible (N526) and 
resistant (N526K) isolates of H. influenzae and H. haemolyticus in Chapter 5, the 
primer set (PBP3-S) designed to amplify N526-positive (BLNAS) isolates performed 
well for the identification of susceptible H. influenzae isolates. However it failed to 
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amplify any H. haemolyticus isolates, irrespective of their N526/N526K status, due 
to a species-specific sequence variation in the forward primer-binding region. The 
discovery of this PCR limitation is significant, as these primers are frequently used in 
respiratory surveillance studies where H. haemolyticus is often mis-identified as H. 
influenzae, and will result in the mis-categorisation of susceptible H. haemolyticus 
isolates as low-BLNAR isolates of H. influenzae.  A new PCR primer set was therefore 
developed to overcome this limitation and was 100% sensitive and specific for the 
separation of N526 isolates (by amplification) from N526K-positive isolates (which 
fail to amplify) of both species. This is an important new tool for the surveillance of 
the N526K-positive BLNAR genotype in XV-dependent Haemophilus species 
commonly encountered in the diagnostic laboratory. 
Chapter 6 explores the main observation made in Chapter 4, that some of the 
BLNAR-associated substitutions reported in N526K-positive isolates of NTHi, appear 
to form part of the baseline PBP3 genotype in susceptible isolates of H. 
haemolyticus. The ftsI gene sequences from 100 clinical isolates, including 
susceptible (N526) and resistant (N526K) H. influenzae and H. haemolyticus isolates, 
were examined using a range of bioinformatic approaches for evidence of inter-
species recombination events. Mosaic ftsI gene sequences were identified in 33% of 
the isolates tested and shown to represent inter-species recombination events. All 
recombination events occurred in N526K-positive isolates of either species and 
frequently resulted in the horizontal transfer of only partial ftsI gene fragments. 
There was no evidence to support the horizontal transfer of the entire ftsI gene 
among the clinical isolates in vivo.  
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Chapter 7 extended on the work of Chapter 6 using an in vitro approach. 
Transformation experiments, using reference recipients and fully characterised 
N526K-positive isolates of H. influenzae and H. haemolyticus as donors, were 
performed to investigate potential inter- and intra-species ftsI recombination 
events. Both inter- and intra-species recombination of the ftsI gene frequently 
occurred in H. influenzae and H. haemolyticus isolates, and resulted in the 
formation of mosaic ftsI genes that carry the N526K-positive resistance genotype. 
In summary, the major findings of this thesis are that a widely used SNP-based PCR 
algorithm is unreliable for N526K-positive BLNAR detection because of a previously 
unrecognized SNP encoding the N526K substitution, and because of ftsI sequence 
divergence with H. haemolyticus that might mis-identify as H. influenzae. As a 
result, a new SNP-based PCR algorithm was developed and shown to be 100% 
sensitive and specific for detection of the N526K substitution. Additionally, this 
thesis presents for the first time the phenotypic and genotypic β-lactam 
susceptibility profiles of H. haemolyticus isolates, and highlights the potential role 
H. haemolyticus plays in the emergence and dissemination of β-lactam resistance 
determinants in H. influenzae. Finally, this thesis has characterised homologous 
(inter- and intra-species) recombination events involving the ftsI gene in both in 
vivo and in vitro models. Such ftsI recombination events were shown to occur 
frequently between H. influenzae and H. haemolyticus isolates, and frequently 
resulted in the formation of mosaic ftsI genes that contribute to the dissemination 
and diversification of the N526K-positive resistance mechanism in Haemophilus 
species. 
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